Medicare can be confusing! Join us for a free educational seminar to get you up to speed on what Medicare covers, what it... New to Medicare? Leaving Employer Soon? Turning 65? Come learn about your options? Medicare can be confusing! Join…
Evommune, Inc. (EVMN) Discusses In Licensing of EVO570 for Autoimmune Diseases November 5, 2026 8:30 AM ESTCompany ParticipantsLuis Peña - Founder,... Evommune, Inc. (EVMN) Discusses In Licensing of EVO570 for Autoimmune Diseases November 5, 2026 8:30 AM EST Luis Peña - Founder, President, CEO & Director Good morning, and thank you…
A recent discovery has found a previously unexamined immune reaction in patients with lupus, a fluctuating disease that causes inflammation and other problems in a variety of organ systems. The researchers observed that the lupus patients in their study have…
Bioengineer.org Subject of Research: Chemogenetic and pharmacological activation of the oxytocin system in a rat model of adjuvant arthritis Article Title: Chemogenetic and pharmacological activation of the oxytocin system ameliorates adjuvant arthritis in rats News Source: Cassandra Pierce. (November…
Newswise — LOS ANGELES (Nov. 5, 2026) -- Cedars-Sinai physicians and scientists from the Kao Autoimmunity Institute will present new research on autoimmune and rheumatologic diseases at ACR Convergence 2026, the American College of Rheumatology (ACR) annual scientific meeting, Nov. 6-11 in Orlando, Florida. Presentations will…
Bioengineer.org Janus kinase inhibitors selectively block intracellular signaling pathways to manage juvenile idiopathic arthritis and associated comorbidities that remain refractory to existing treatments, according to a peer-reviewed review published in BMC Rheumatology Authors Anna Tryfonos, Jennifer L Huggins, and…
A 78-year-old man with pneumoconiosis and markedly elevated pleural adenosine deaminase levels initially suspected of having tuberculous pleuritis was ultimately diagnosed with late-onset systemic lupus erythematosus despite low-titre antinuclear antibody results. The broader message for clinicians is that markedly elevated…
In this clip, Amanda L. Piquet, MD, discusses the significant unmet treatment needs facing patients with stiff person syndrome (SPS), a debilitating autoimmune neurologic disease. Drawing on findings from the phase 2 KYSA-8 study evaluating CD19-directed CAR T-cell therapy mivocabtagene autoleucel (miv-cel),…
In this segment, Dr. Mark Dailey, Dr. Caron A. Jacobson, and NP Stefanie Sigmund introduce the challenges of coordinating chimeric antigen receptor (CAR) T-cell therapy for patients with diffuse large B-cell lymphoma (DLBCL), particularly those who must travel long distances to…
- In this segment, Dr. Caron A. Jacobson discusses strategies to streamline referrals for chimeric antigen receptor (CAR) T-cell therapy in patients with diffuse large B-cell lymphoma (DLBCL). She emphasizes the importance of understanding how CAR T-cell services are organized at the…
Arthritis, lupus, vasculitis, biologics, and immune‑modulating therapies.
An article joins this feed when it matches these terms. Each one is also a search of its own.